`
Transparency Market Research Aptamers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
Published Date 2014-06-18
94 Page Report
Buy Now
Request Sample
Press Release
Aptamers Market Expected to Reach USD 4.33 Billion Globally in 2019 Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
Aptamers Market
REPORT DESCRIPTION
Aptamers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019 According to a new market report published by Transparency Market Research Aptamers Market (By Types - Nucleic Acid Aptamers and Peptide Aptamers; By Applications - Therapeutics Development, Diagnostics, Research and Development Applications and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019, the global aptamers market was valued at USD 93.0 million in 2012 and is estimated to reach USD 4,333.0 million in 2019, growing at a CAGR of 73.1% from 2013 to 2019. Aptamers are single-stranded nucleic acid oligonucleotide or peptide molecules. Aptamers can bind with a range of target molecules such as proteins, carbohydrates, ions and viruses. Aptamer technology is widely used in laboratory diagnosis, molecular recognition, pharmaceutical studies, drug discovery and disease treatment. Moreover, these play an important role in the production of improved and cost-effective medicines. Increasing scientific research activities in aptamer technology and rising participation of private organizations for the development of aptamers would boost the growth of the aptamers market globally. Furthermore, collaboration of key players to develop innovative aptamer technologies would drive market growth. For example, Aptamer Group focuses on collaborating with government agencies and academic partners for the development of effective and innovative aptamer technologies. These collaborations would establish a healthy platform for the development of aptamers, which in turn would accelerate market growth. However, strict regulations and ethical issues related to aptamers would restrain the growth of the market.
Browse the full Aptamers Market Report @ : http://www.transparencymarketresearch.com/aptamers-market.html The aptamers market is segmented by types and by applications. The aptamers market by types is segmented into nucleic acid aptamers and peptide aptamers. The nucleic acid aptamers segment accounted for the largest share of the aptamers market in 2012. It is expected to dominate the market during the forecast period. Growth in this segment is attributed to increasing use of nucleic acid aptamers in research and development. Additionally, nucleic acid aptamers is projected to be the fastest growing segment during the forecast period. The aptamers market, by application is segmented into therapeutics development, diagnostics,
Transparency Market Research
2
Aptamers Market
research and development applications and others. The diagnostics application segment is likely to grow consistently due to increasing use of aptamers in biomedical diagnostics, molecular imaging and development of disease related biomarkers. However, the therapeutics development application segment is estimated to grow at the highest CAGR due to increasing research and development activities in aptamer technology to develop novel therapeutic agents.
Browse the full Aptamers Market Press Release @ : http://www.transparencymarketresearch.com/pressrelease/aptamersmarket.htm North America accounted for the largest share of the global aptamers market in 2012. Presence of a large number of key players and increasing research and development activities in aptamer technology in North America are the major factors contributing to the growth of aptamers market. Europe accounted for the second largest share i.e., over 35% of the total market in 2012. The aptamers market is majorly driven by increasing use of aptamer technologies by small-scale industries in Europe. Asia-Pacific is expected to grow at the highest CAGR from 2013 to 2019 due to increasing initiatives undertaken by governments for the development of aptamers. There is intense competition in the global aptamers market. Manufacturers are increasing their investment in aptamer technology. The global aptamers market includes major companies such as Somalogic, Inc., NOXXAN Pharma AG, Aptamer Science, Inc. and Aptagen, Inc.
Get Free Sample Report : http://www.transparencymarketresearch.com/sample/sample.php? flag=s&rep_id=1335 The global aptamers market is segmented into the following categories: Aptamers Market, by Types •
Nucleic Acid Aptamers
•
Peptide Aptamers
Aptamers Market, by Applications •
Therapeutics Development
•
Diagnostics
Transparency Market Research
3
Aptamers Market
•
Research and Development Application
•
Others
Aptamers Market, by Geography •
North America
•
Europe
•
Asia-Pacific
•
Rest of World (RoW)
TABLE OF CONTENT
Chapter 1 Introduction 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.3.1 Sources 1.3.1.1 Secondary Research 1.3.1.2 Primary Research 1.3.1.3 Assumptions 1.4 List of Abbreviations
Chapter 2 Executive Summary 2.1 Market Snapshot: Global Aptamers Market (2012 & 2019)
Transparency Market Research
4
Aptamers Market
2.1.1 Global Aptamers Market by Types, 2012 (USD Million) 2.2 Comparative Analysis: Global Aptamers Market, By Geography, 2012 and 2019 (Value %)
Chapter 3 Market Overview 3.1 Overview 3.2 Event Impact Analysis 3.3 Market Dynamics 3.3.1 Market Drivers 3.3.1.1 Increasing interest of research scientists in the field of aptamer technology owing to various advantages over antibodies 3.3.1.2 Rising support and participation of private organizations aiming to increase advancements in aptamer field 3.3.2 Market Restraints 3.3.2.1 Inadequate regulatory policies and ethical issues related to aptamer development 3.3.2.2 Lack of knowledge and unfavorable characteristics of aptamers will lead low acceptance 3.3.3 Market Opportunities 3.3.3.1 Modification in aptamer chemistry will offer high acceptance 3.4 Porter’s Five Force Analysis 3.4.1 Bargaining power of suppliers – Low - Medium 3.4.2 Bargaining power of buyers – Low - Medium
Transparency Market Research
5
Aptamers Market
3.4.3 Threat of substitutes – High – Medium 3.4.4 Threat of new entrants – Medium - High 3.4.5 Competitive rivalry – Low - Medium 3.5 Market Attractiveness Analysis: Global Aptamers Market, by Geography
Chapter 4 Aptamers Market, by Types 4.1 Introduction 4.1.1 Global Aptamers Market Revenue, by Types, 2011 – 2019 (USD Million) 4.2 Nucleic Acid Aptamers 4.2.1 Global Nucleic Acid Aptamers Market Revenue, 2011 – 2019 (USD Million) 4.3 Peptide Aptamers 4.3.1 Global Peptide Aptamers Market Revenue, 2011 – 2019 (USD Million)
Chapter 5 Aptamers Market, by Applications 5.1 Overview 5.1.1 Global Aptamers Market Revenue, by Applications, 2011 – 2019 (USD Million) 5.2 Therapeutics Development 5.2.1 Global Therapeutics Development Application Market Revenue, 2011 – 2019 (USD Million) 5.3 Diagnostics (Molecular Imaging, Biomarker Detection and Discovery) 5.3.1 Global Diagnostics Application Market Revenue, 2011 – 2019 (USD Million)
Transparency Market Research
6
Aptamers Market
5.4 Research and Development Applications (Targeted Drug Delivery, Drug Discovery and Development) 5.4.1 Global Research and Development Application Market Revenue, 2011 – 2019 (USD Million) 5.5 Others (Biosensor and Food Safety) 5.5.1 Global Others Application Market Revenue, 2011 – 2019 (USD Million)
Chapter 6 Aptamers Market, by Geography 6.1 Overview 6.1.1 Global Aptamers Market Revenue, by Geography, 2011 – 2019 (USD Million) 6.2 North America 6.2.1 North America Aptamers Market Revenue, 2011 – 2019 (USD Million) 6.3 Europe 6.3.1 Europe Aptamers Market Revenue, 2011 – 2019 (USD Million) 6.4 Asia-Pacific 6.4.1 Asia-Pacific Aptamers Market Revenue, 2011 – 2019 (USD Million) 6.5 Rest of the World (RoW) 6.5.1 RoW Aptamers Market Revenue, 2011 – 2019 (USD Million)
Chapter 7 Competitive Landscape 7.1 Market Share by Key Players of Global Aptamers Market, 2012 (%)
Transparency Market Research
7
Aptamers Market
7.1.1 Global Aptamers Market Share Analysis, by Key Players, 2012 (%)
Chapter 8 Recommendations 8.1 Market Strategy for Success 8.1.1 Focus on emerging aptamer selection technologies that improves aptamer affinity and specificity 8.1.2 Focus on investing in research and development activities
Chapter 9 Company Profiles 9.1 AM Biotechnologies, LLC 9.1.1 Company Overview 9.1.2 Financial Overview 9.1.3 Product Portfolio 9.1.4 Business Strategies 9.1.5 Recent Developments 9.2 Aptagen, LLC 9.2.1 Company Overview 9.2.2 Financial Overview 9.2.3 Product Portfolio 9.2.4 Business Strategies 9.2.5 Recent Developments
Transparency Market Research
8
Aptamers Market
9.3 Aptamer group 9.3.1 Company Overview 9.3.2 Financial Overview 9.3.3 Product Portfolio 9.3.4 Business Strategies 9.3.5 Recent Developments 9.4 Aptamer Sciences, Inc. 9.4.1 Company Overview 9.4.2 Financial Overview 9.4.3 Product Portfolio 9.4.4 Business Strategies 9.4.5 Recent Developments 9.5 Base Pair Biotechnologies, Inc. 9.5.1 Company Overview 9.5.2 Financial Overview 9.5.3 Product Portfolio 9.5.4 Business Strategies 9.5.5 Recent Developments 9.6 Bioapter S.L. 9.6.1 Company Overview
Transparency Market Research
9
Aptamers Market
9.6.2 Financial Overview 9.6.3 Product Portfolio 9.6.4 Business Strategies 9.7 CD Genomics 9.7.1 Company Overviews 9.7.2 Financial Overview 9.7.3 Product Portfolio 9.7.4 Business Strategies 9.8 Neo Ventures Biotechnology, Inc. 9.8.1 Company Overview 9.8.2 Financial Overview 9.8.3 Product Portfolio 9.8.4 Business Strategies 9.8.5 Recent Developments 9.9 NOXXON Pharma AG 9.9.1 Company Overview 9.9.2 Financial Overview 9.9.3 Product Portfolio 9.9.4 Business Strategies 9.9.5 Recent Developments
Transparency Market Research
10
Aptamers Market
9.10 Optech Biotech 9.10.1 Company Overview 9.10.2 Financial Overview 9.10.3 Product Portfolio 9.10.4 Business Strategies 9.10.5 Recent Developments 9.11 Ophthotech Corporation 9.11.1 Company Overview 9.11.2 Product Portfolio 9.11.3 Business Strategies 9.12 Regado Biosciences, Inc. 9.12.1 Company Overview 9.12.2 Financial Overview 9.12.3 Product Portfolio 9.12.4 Business Strategies 9.12.5 Recent Developments 9.13 Somalogic, Inc. 9.13.1 Company Overview 9.13.2 Financial Overview 9.13.3 Product Portfolio
Transparency Market Research
11
Aptamers Market
9.13.4 Business Strategies 9.13.5 Recent Developments 9.14 TriLink Biotechnologies, Inc. 9.14.1 Company Overview 9.14.2 Financial Overview 9.14.3 Product Portfolio 9.14.4 Business Strategies 9.14.5 Recent Developments 9.15 Vivonics, Inc. 9.15.1 Company Overview 9.15.2 Financial Overview 9.15.3 Product Portfolio 9.15.4 Business Strategies 9.15.5 Recent Developments List of Figures
FIG. 1 Aptamers Market Segmentation FIG. 2 Global Aptamers Market, by Types, 2012 (USD Million) FIG. 3 Comparative Analysis: Global Aptamers Market, by Geography, 2012 and 2019 (Value %) FIG. 4 Porter’s Five Forces Analysis: Global Aptamers Market
Transparency Market Research
12
Aptamers Market
FIG. 5 Market Attractiveness Analysis: Global Aptamers Market, by Geography, 2012 Value (%) FIG. 6 Global Nucleic Acid Aptamers Market Revenue, 2011 – 2019 (USD Million) FIG. 7 Global Peptide Aptamers Market Revenue, 2011 – 2019 (USD Million) FIG. 8 Global Therapeutics Development Application Market Revenue, 2011 – 2019 (USD Million) FIG. 9 Global Diagnostics Application Market Revenue, 2011 – 2019 (USD Million) FIG. 10 Global Research and Development Application Market Revenue, 2011 – 2019 (USD Million) FIG. 11 Global Others Application Market Revenue, 2011 – 2019 (USD Million) FIG. 12 North America Aptamers Market Revenue, 2011 – 2019 (USD Million) FIG. 13 Europe Aptamers Market Revenue, 2011 – 2019 (USD Million) FIG. 14 Asia-Pacific Aptamers Market Revenue, 2011 – 2019 (USD Million) FIG. 15 RoW Aptamers Market Revenue, 2011 – 2019 (USD Million) FIG. 16 Global Aptamers Market: Market Share, by Key Players, 2012 (%) List of Table
TABLE 1 List of Abbreviations TABLE 2 Market Snapshot: Global Aptamers Market (2012 & 2019) TABLE 3 Impact Analysis of Market Drivers TABLE 4 Impact Analysis of Market Restraints TABLE 5 Global Aptamers Market Revenue, by Types, 2011 – 2019 (USD Million)
Transparency Market Research
13
Aptamers Market
TABLE 6 Global Aptamers Market Revenue, by Applications, 2011 – 2019 (USD Million) TABLE 7 Global Aptamers Market Revenue, by Geography, 2011 – 2019 (USD Million)
Browse All Biotechnology Market Research Reports @ http://www.transparencymarketresearch.com/biotechnology-market-reports18.html About Us
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/
Transparency Market Research
14